لووتیروکسین سدیم (Levothyroxine Sodium)
۲۶۹ محصول ثبت‌شده نسخه‌ای ANDANDA
خلاصهٔ ثبت FDA
- فرم‌های دارویی
- TABLET;ORAL · CAPSULE;ORAL · POWDER;INTRAVENOUS
- دوزهای ثبت‌شده
- 0.15MG · 0.175MG · 0.2MG · 0.075MG
- شرکت‌های دارنده
- IBSA · MYLAN · STEVENS J · ALVOGEN
- پروندهٔ رسمی
- 021924
محصولات ثبت‌شده (نمایش ۸۰ از ۲۶۹)
| نام محصول | فرم | دوز | شرکت | نوع | وضعیت | پرونده |
|---|---|---|---|---|---|---|
| THYRO-TABS | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ALVOGEN | NDA | نسخه‌ای | 021116 |
| THYRO-TABS | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ALVOGEN | NDA | نسخه‌ای | 021116 |
| THYRO-TABS | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ALVOGEN | NDA | نسخه‌ای | 021116 |
| THYRO-TABS | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ALVOGEN | NDA | نسخه‌ای | 021116 |
| THYRO-TABS | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ALVOGEN | NDA | نسخه‌ای | 021116 |
| THYRO-TABS | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ALVOGEN | NDA | نسخه‌ای | 021116 |
| THYRO-TABS | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ALVOGEN | NDA | نسخه‌ای | 021116 |
| THYRO-TABS | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ALVOGEN | NDA | نسخه‌ای | 021116 |
| THYRO-TABS | TABLET;ORAL | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ALVOGEN | NDA | نسخه‌ای | 021116 |
| THYRO-TABS | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ALVOGEN | NDA | نسخه‌ای | 021116 |
| THYRO-TABS | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ALVOGEN | NDA | نسخه‌ای | 021116 |
| THYRO-TABS | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ALVOGEN | NDA | نسخه‌ای | 021116 |
| LEVOLET | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | GENUS LIFESCIENCES | NDA | نسخه‌ای | 021137 |
| LEVOLET | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | GENUS LIFESCIENCES | NDA | نسخه‌ای | 021137 |
| LEVOLET | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | GENUS LIFESCIENCES | NDA | نسخه‌ای | 021137 |
| LEVOLET | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | GENUS LIFESCIENCES | NDA | نسخه‌ای | 021137 |
| LEVOLET | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | GENUS LIFESCIENCES | NDA | نسخه‌ای | 021137 |
| LEVOLET | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | GENUS LIFESCIENCES | NDA | نسخه‌ای | 021137 |
| LEVOLET | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | GENUS LIFESCIENCES | NDA | نسخه‌ای | 021137 |
| LEVOLET | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | GENUS LIFESCIENCES | NDA | نسخه‌ای | 021137 |
| LEVOLET | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | GENUS LIFESCIENCES | NDA | نسخه‌ای | 021137 |
| LEVOLET | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | GENUS LIFESCIENCES | NDA | نسخه‌ای | 021137 |
| LEVOLET | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | GENUS LIFESCIENCES | NDA | نسخه‌ای | 021137 |
| LEVOLET | TABLET;ORAL | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | GENUS LIFESCIENCES | NDA | نسخه‌ای | 021137 |
| UNITHROID | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | STEVENS J | NDA | نسخه‌ای | 021210 |
| UNITHROID | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | STEVENS J | NDA | نسخه‌ای | 021210 |
| UNITHROID | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | STEVENS J | NDA | نسخه‌ای | 021210 |
| UNITHROID | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | STEVENS J | NDA | نسخه‌ای | 021210 |
| UNITHROID | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | STEVENS J | NDA | نسخه‌ای | 021210 |
| UNITHROID | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | STEVENS J | NDA | نسخه‌ای | 021210 |
| UNITHROID | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | STEVENS J | NDA | نسخه‌ای | 021210 |
| UNITHROID | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | STEVENS J | NDA | نسخه‌ای | 021210 |
| UNITHROID | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | STEVENS J | NDA | نسخه‌ای | 021210 |
| UNITHROID | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | STEVENS J | NDA | نسخه‌ای | 021210 |
| UNITHROID | TABLET;ORAL | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | STEVENS J | NDA | نسخه‌ای | 021210 |
| UNITHROID | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | STEVENS J | NDA | نسخه‌ای | 021210 |
| EUTHYROX | TABLET;ORAL | 0.025MG | EMD SERONO INC | NDA | متوقف‌شده | 021292 |
| EUTHYROX | TABLET;ORAL | 0.05MG | EMD SERONO INC | NDA | متوقف‌شده | 021292 |
| EUTHYROX | TABLET;ORAL | 0.075MG | EMD SERONO INC | NDA | متوقف‌شده | 021292 |
| EUTHYROX | TABLET;ORAL | 0.088MG | EMD SERONO INC | NDA | متوقف‌شده | 021292 |
| EUTHYROX | TABLET;ORAL | 0.1MG | EMD SERONO INC | NDA | متوقف‌شده | 021292 |
| EUTHYROX | TABLET;ORAL | 0.112MG | EMD SERONO INC | NDA | متوقف‌شده | 021292 |
| EUTHYROX | TABLET;ORAL | 0.125MG | EMD SERONO INC | NDA | متوقف‌شده | 021292 |
| EUTHYROX | TABLET;ORAL | 0.137MG | EMD SERONO INC | NDA | متوقف‌شده | 021292 |
| EUTHYROX | TABLET;ORAL | 0.15MG | EMD SERONO INC | NDA | متوقف‌شده | 021292 |
| EUTHYROX | TABLET;ORAL | 0.175MG | EMD SERONO INC | NDA | متوقف‌شده | 021292 |
| EUTHYROX | TABLET;ORAL | 0.2MG | EMD SERONO INC | NDA | متوقف‌شده | 021292 |
| EUTHYROX | TABLET;ORAL | 0.3MG | EMD SERONO INC | NDA | متوقف‌شده | 021292 |
| LEVOXYL | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | KING PHARMS | NDA | نسخه‌ای | 021301 |
| LEVOXYL | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | KING PHARMS | NDA | نسخه‌ای | 021301 |
| LEVOXYL | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | KING PHARMS | NDA | نسخه‌ای | 021301 |
| LEVOXYL | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | KING PHARMS | NDA | نسخه‌ای | 021301 |
| LEVOXYL | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | KING PHARMS | NDA | نسخه‌ای | 021301 |
| LEVOXYL | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | KING PHARMS | NDA | نسخه‌ای | 021301 |
| LEVOXYL | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | KING PHARMS | NDA | نسخه‌ای | 021301 |
| LEVOXYL | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | KING PHARMS | NDA | نسخه‌ای | 021301 |
| LEVOXYL | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | KING PHARMS | NDA | نسخه‌ای | 021301 |
| LEVOXYL | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | KING PHARMS | NDA | نسخه‌ای | 021301 |
| LEVOXYL | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | KING PHARMS | NDA | نسخه‌ای | 021301 |
| LEVOXYL | TABLET;ORAL | 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | KING PHARMS | NDA | متوقف‌شده | 021301 |
| LEVO-T | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | CEDIPROF INC | NDA | نسخه‌ای | 021342 |
| LEVO-T | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | CEDIPROF INC | NDA | نسخه‌ای | 021342 |
| LEVO-T | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | CEDIPROF INC | NDA | نسخه‌ای | 021342 |
| LEVO-T | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | CEDIPROF INC | NDA | نسخه‌ای | 021342 |
| LEVO-T | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | CEDIPROF INC | NDA | نسخه‌ای | 021342 |
| LEVO-T | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | CEDIPROF INC | NDA | نسخه‌ای | 021342 |
| LEVO-T | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | CEDIPROF INC | NDA | نسخه‌ای | 021342 |
| LEVO-T | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | CEDIPROF INC | NDA | نسخه‌ای | 021342 |
| LEVO-T | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | CEDIPROF INC | NDA | نسخه‌ای | 021342 |
| LEVO-T | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | CEDIPROF INC | NDA | نسخه‌ای | 021342 |
| LEVO-T | TABLET;ORAL | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | CEDIPROF INC | NDA | نسخه‌ای | 021342 |
| LEVO-T | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | CEDIPROF INC | NDA | نسخه‌ای | 021342 |
| SYNTHROID | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ABBVIE | NDA | نسخه‌ای | 021402 |
| SYNTHROID | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ABBVIE | NDA | نسخه‌ای | 021402 |
| SYNTHROID | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ABBVIE | NDA | نسخه‌ای | 021402 |
| SYNTHROID | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ABBVIE | NDA | نسخه‌ای | 021402 |
| SYNTHROID | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ABBVIE | NDA | نسخه‌ای | 021402 |
| SYNTHROID | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ABBVIE | NDA | نسخه‌ای | 021402 |
| SYNTHROID | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ABBVIE | NDA | نسخه‌ای | 021402 |
| SYNTHROID | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | ABBVIE | NDA | نسخه‌ای | 021402 |
این پرونده از کجا می‌آید؟
داده‌ها از فایل‌های رسمی Drugs@FDA data files (Products، Applications و MarketingStatus) گرفته شده‌اند. هر ردیف جدول یک محصول ثبت‌شده با همان مادهٔ مؤثره است؛ شمارهٔ پرونده به صفحهٔ رسمی FDA لینک دارد. وضعیت «متوقف‌شده» یعنی محصول دیگر توزیع نمی‌شود.
خبر دارو و سلامت را
از دست ندهید
روزی چند گزارش کوتاه، بدون تبلیغ و بدون اسپم.